Penumbra (PEN) Net Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.00 |
| Dec 31, 2025 | 1,052.00 |
| Sep 30, 2025 | 1,398.00 |
| Jun 30, 2025 | 1,511.00 |
| Mar 31, 2025 | 1,207.00 |
| Dec 31, 2024 | 2,275.00 |
| Sep 30, 2024 | 265.00 |
| Jun 30, 2024 | -2,460.00 |
| Mar 31, 2024 | -523.00 |
| Dec 31, 2023 | 1,525.00 |
| Sep 30, 2023 | 815.00 |
| Jun 30, 2023 | 1,797.00 |
| Mar 31, 2023 | 230.00 |
| Dec 31, 2022 | -484.00 |
| Sep 30, 2022 | -923.00 |
| Jun 30, 2022 | -1,381.00 |
| Mar 31, 2022 | -815.00 |
| Dec 31, 2021 | -1,728.00 |
| Sep 30, 2021 | 2,626.00 |
| Jun 30, 2021 | -770.00 |
| Mar 31, 2021 | 384.00 |
| Dec 31, 2020 | -566.00 |
| Sep 30, 2020 | -504.00 |
| Jun 30, 2020 | -879.00 |
| Mar 31, 2020 | 548.00 |
| Dec 31, 2019 | 987.00 |
| Sep 30, 2019 | -956.00 |
| Jun 30, 2019 | 741.00 |
| Mar 31, 2019 | 424.00 |
| Dec 31, 2018 | 221.00 |
| Sep 30, 2018 | -1,967.00 |
| Jun 30, 2018 | 1,351.00 |
| Mar 31, 2018 | 406.00 |
| Dec 31, 2017 | 923.00 |
| Sep 30, 2017 | 396.00 |
| Jun 30, 2017 | -219.00 |
| Mar 31, 2017 | -531.00 |